CROI 2015 Program and Abstracts

Keyword Index

KEYWORD INDEX

12-week use; 524 2-LTR circles; 374 2B4; 389LB 3TC; 863, 863 4E10 epitope; 356 4th-generation immunoassay; 613, 620 – A – Abacavir; 735, 736, 749LB, 782 Abortive infection; 202 Abstinence; 160 ACA; 1066 Acceptability; 955 Access to care; 1066, 1078 Accessory proteins; 123 Acetylation; 404 Acquired drug resistance; 553, 607 Acquired immunodeficiency syndrome; 297 Activation; 321 Acute • HIV; 47, 48, 272, 305, 359, 438, 473, 841, 961, 961, 1003, 1007, 1116, 1021, 1043, 1044, 1069 Adherence; 83, 117, 294, 514, 546, 557, 560, 692, 694, 827LB, 853, 875, 886, 887, 888, 907, 975, 976, 977, 979, 980, 990, 992LB Adipokine; 770 Adipose tissue; 744 Administrative data; 1054 Adolescents; 241, 250, 450, 918, 943, 944, 950, 952, 953 Adults; 115LB, 462, 628, 1076 Adverse events; 829 Advocacy; 6 Africa; 37, 57, 88, 154, 622, 544, 552, 555, 573, 622, 629, 722, 764, 793, 809, 907, 929, 941, 969, 1014, 1034, 1059, 1078, 1079 African; 808, 933 African American; 850 Age; 742 Aging; 84, 306, 307, 485, 492, 495, 499, 506, 725, 741, 783, 785, 786, 881, 923, 1053 Agonistic antibody; 358 AIDS; 308, 496, 1104 • Diagnoses rates; 999 • Events; 562 • Indicator survey; 1037 AIDS-free survival; 1009 AIDS-related malignancy; 69 Albuminuria; 796 Alcohol; 639, 804, 808, 852, 925, 1005, 1036, 1037, 1038, 1050 Alere PIMA; 632LB Alere q; 34 Algorithm; 633 • Hepatitis C; 669, 670, 671, 674, 678 • Infection; 218, 364, 613, 620, 702, 866 • Myocardial infarction; 746 • Virus; 215 Acylcarnitines; 498, 880 Acylguanidines; 536 Adeno-associated virus; 163, 400

Allelic exclusion; 277 Allograft rejection; 798 Allometry; 949 Allo SCT; 431 Allosteric inhibitor; 540

Antiviral activity; 114LB, 287, 527 Antiviral immune response; 569 Antiviral therapy; 656 Aorta; 753 APOBEC3; 194 APOBEC3G/F; 193 APOE; 463 APOL1; 933 APOL6; 191, 191

Alpha 4 beta 7; 217 ALVAC/AIDSVAX; 166 Amyloid; 208, 209, 482, 483 Anaerobes; 1085 Anal cancer; 90, 715 Anal swabs; 568 Analytic treatment interruption (ATI); 352, 378, 434 Anatomic compartments; 435, 525 Ancestry; 933 Anergy; 284 Angiographic restenosis; 730 Anthropometric; 762 Anti-HB antibody seroconversion; 703 Anti-HBs antibodies; 701 Anti-HBs titers; 700 Anti-PD-L1; 371 Antibodies; 64, 163, 170LB, 834, 259, 340, 589, 834, 903, 905 Antibody response; 430, 987 Antibody-dependent cell-mediated cytotoxicity (ADCC); 162 Antidiabetics; 531 Antigen-specific responses; 330 Antigen/antibody assays; 618 Antiretroviral; 33, 38LB, 57, 142, 451, 513, 519, 522, 540, 555, 574, 793, 882, 886, 896, 1079, 1114 • Drug; 116, 265, 444, 818 • Drug transporters; 534, 534 • Failure; 606 • Nanomedicine; 528 • Pharmacokinetics; 83, 84, 509, 525 • Tissue penetration; 548 • Treatment; 1118 Antiretroviral therapy (ART); 29, 35, 36, 56, 88, 108, 155, 157, 159, 161, 297, 305, 322, 332, 396, 343, 376, 389LB, 435, 436, 445, 450, 466, 546, 557, 559, 563, 565, 570, 576, 578, 579, 580, 583, 584, 597, 600, 615, 638, 720, 721, 738, 739, 805, 808, 810, 832, 835, 837, 853, 864, 865, 866, 875, 887, 888, 913, 915, 920, 929, 945, 946, 984, 989, 990, 997, 998, 1001, 1011, 1012, 1023, 1056, 1059, 1077, 1080, 1084, 1094, 1095, 1106, 1110, 1112, 1119, 1120 • Adherence; 8 • Care evaluation; 561 • Cascade; 1008 • Coverage; 535, 1064 • Initiation; 270, 575, 778, 836, 1001, 1007, 1012, 1081, 1112 • Intensification; 271 • Naive; 780 • Outcomes; 155, 566 • Patients; 381 • Programmonitoring; 561 • Scale-up; 159, 1071 • Switch; 118, 733 Antituberculosis treatment; 95LB

Apoptosis; 387, 411 Aqueous humor; 848 ARS; 1044 Arterial inflammation; 738 Arterial stiffness; 925 Asia; 915 Asian; 703 Assay; 91, 612

Astrocyte; 473, 478, 507, 508 Asunaprevir; 146, 683, 687, 688 Asymmetric dimethylarginine (ADMA); 758 Asymptomatic neurocognitive impairment; 465 Atazanavir; 515, 794 Atazanavir/ritonavir; 520 Atherosclerosis; 136, 752, 755, 926 Atorvastatin; 136 Atorvastatin adjunct therapy; 322 Atovaquone; 520 Atripla; 871, 878 Attachment inhibitor; 509, 523, 545 Attributable; 1038 Attrition; 881 ATV/r monotherapy; 442, 443, 773 Autologous HIV-1; 199 Autologous stem cell transplantation; 429 Autophagy; 395, 410 Autophagy-related protein 7; 410 Autopsy; 825

Avidity; 623, 1042 Awareness; 1014 Azithromycin; 845 – B – B cell follicle; 370 B cell responses; 342 B cells; 166, 339, 340, 341 Bacillary load; 819 Bacterial functions; 260 Bacterial vaginosis; 861

Balance; 786 BCG; 279, 948 Bcl-2; 411 Behavioral; 74 Beta catenin; 507 Bias; 1030 Bifurcation; 754 Bio-rad avidity enzyme immunoassay; 625, 625

Keyword Index

Biodegradable; 542 Bioenergetics; 497 Bioinformatics; 13, 261 Biologic measure; 1030

682

CROI 2015